✦ LIBER ✦

Economic evaluation of sunitinib malate in second-line treatment of metastatic renal cell carcinoma in Finland

✍ Scribed by Timo Purmonen; Janne A. Martikainen; Erkki J.O. Soini; Vesa Kataja; Riikka-Liisa Vuorinen; Pirkko-Liisa Kellokumpu-Lehtinen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN46 PHARMACOECONOMIC EVALUATION OF SUN

✍ C Tenorio; J Vargas; P Rizo-Rios; O Flores-Gil; J Martínez-Fonseca; J Mould-Quev 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Second-Line Treatment Outcomes After Fir

✍ Chi-Chang Chen; Gregory P. Hess; Zhimei Liu; Dean H. Gesme; Sanjiv S. Agarwala; 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 284 KB

PCN15 COST-EFFECTIVENESS OF NEW TARGETED

✍ EC Aiello; N Muszbek; E Richardet; A Lingua; C Charbonneau; E Remák 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

PCN80 Economic Evaluation of Sunitinib f

✍ Yagudina, R.; Kulikov, A.; Novikov, I. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCN108 Economic Evaluation of Sunitinib

✍ Wu, J.; Zhang, N.; Dong, P. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCN48 SUNITINIB MALATE PROVIDES ADDITION

✍ T Purmonen; JA Martikainen; EJ Soini; V Kataja; P Kellokumpu-Lehtinen 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB